It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Less than 48 hours after their season came to an end, the Lions lost again. On Monday, Ben Johnson decided to leave his post as Detroit's offensive coordinator. He will reportedly stay in the NFC ...

In an alternate universe, Ben Johnson could be coaching against the Detroit Lions this week in the NFC playoffs. Johnson was widely considered the frontrunner for the Washington Commanders vacant ...

Speaker Mike Johnson is replacing Rep. Mike Turner as chairman of the House Intelligence Committee after a debacle that started with a warning about Russian space nuclear technology last year ...

The 2025 NFL free agency period will be a little different, however. Armed with new head coach Ben Johnson, there's logic in predicting the Bears will target some of his former players who can ...

One prospect you haven't heard as much about lately is second baseman Termarr Johnson, who has seen his prospect star fade recently. According to MLB Pipeline, Johnson was the No. 26 prospect in ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...